Platelet  ||| S:0 E:9 ||| JJ
collection  ||| S:9 E:20 ||| NN
efficiencies  ||| S:20 E:33 ||| NNS
of  ||| S:33 E:36 ||| IN
three  ||| S:36 E:42 ||| CD
different  ||| S:42 E:52 ||| JJ
platelet-rich  ||| S:52 E:66 ||| JJ
plasma  ||| S:66 E:73 ||| JJ
preparation  ||| S:73 E:85 ||| NN
systems  ||| S:85 E:93 ||| NNS
Different  ||| S:93 E:103 ||| JJ
systems  ||| S:103 E:111 ||| NNS
have  ||| S:111 E:116 ||| VBP
been  ||| S:116 E:121 ||| VBN
used  ||| S:121 E:126 ||| VBN
for  ||| S:126 E:130 ||| IN
the  ||| S:130 E:134 ||| DT
preparation  ||| S:134 E:146 ||| NN
of  ||| S:146 E:149 ||| IN
platelet-rich  ||| S:149 E:163 ||| JJ
plasma  ||| S:163 E:170 ||| NNS
( ||| S:170 E:171 ||| -LRB-
PRP ||| S:171 E:174 ||| NNP
) ||| S:174 E:175 ||| -RRB-
,  ||| S:175 E:177 ||| ,
but  ||| S:177 E:181 ||| CC
platelet  ||| S:181 E:190 ||| JJ
collection  ||| S:190 E:201 ||| NN
efficiencies  ||| S:201 E:214 ||| NNS
of  ||| S:214 E:217 ||| IN
these  ||| S:217 E:223 ||| DT
systems  ||| S:223 E:231 ||| NNS
are  ||| S:231 E:235 ||| VBP
not  ||| S:235 E:239 ||| RB
clear ||| S:239 E:244 ||| JJ
.  ||| S:244 E:246 ||| .
To  ||| S:246 E:249 ||| TO
evaluate  ||| S:249 E:258 ||| VB
the  ||| S:258 E:262 ||| DT
platelet  ||| S:262 E:271 ||| JJ
collection  ||| S:271 E:282 ||| NN
efficiencies  ||| S:282 E:295 ||| NNS
of  ||| S:295 E:298 ||| IN
three  ||| S:298 E:304 ||| CD
different  ||| S:304 E:314 ||| JJ
PRP  ||| S:314 E:318 ||| NNP
preparation  ||| S:318 E:330 ||| NN
systems ||| S:330 E:337 ||| NNS
.  ||| S:337 E:339 ||| .
Blood  ||| S:339 E:345 ||| NN
samples  ||| S:345 E:353 ||| NNS
were  ||| S:353 E:358 ||| VBD
obtained  ||| S:358 E:367 ||| VBN
from  ||| S:367 E:372 ||| IN
the  ||| S:372 E:376 ||| DT
same  ||| S:376 E:381 ||| JJ
16  ||| S:381 E:384 ||| CD
volunteers  ||| S:384 E:395 ||| NNS
for  ||| S:395 E:399 ||| IN
each  ||| S:399 E:404 ||| DT
system ||| S:404 E:410 ||| NN
.  ||| S:410 E:412 ||| .
The  ||| S:412 E:416 ||| DT
samples  ||| S:416 E:424 ||| NNS
were  ||| S:424 E:429 ||| VBD
centrifuged  ||| S:429 E:441 ||| JJ
and  ||| S:441 E:445 ||| CC
PRP  ||| S:445 E:449 ||| NNP
was  ||| S:449 E:453 ||| VBD
prepared  ||| S:453 E:462 ||| VBN
by  ||| S:462 E:465 ||| IN
three  ||| S:465 E:471 ||| CD
systems ||| S:471 E:478 ||| NNS
.  ||| S:478 E:480 ||| .
The  ||| S:480 E:484 ||| DT
ratio  ||| S:484 E:490 ||| NN
of  ||| S:490 E:493 ||| IN
the  ||| S:493 E:497 ||| DT
total  ||| S:497 E:503 ||| JJ
number  ||| S:503 E:510 ||| NN
of  ||| S:510 E:513 ||| IN
platelets  ||| S:513 E:523 ||| NN
in  ||| S:523 E:526 ||| IN
PRP  ||| S:526 E:530 ||| NNP
to  ||| S:530 E:533 ||| TO
the  ||| S:533 E:537 ||| DT
total  ||| S:537 E:543 ||| JJ
number  ||| S:543 E:550 ||| NN
of  ||| S:550 E:553 ||| IN
platelets  ||| S:553 E:563 ||| NN
of  ||| S:563 E:566 ||| IN
the  ||| S:566 E:570 ||| DT
venous  ||| S:570 E:577 ||| JJ
blood  ||| S:577 E:583 ||| NN
sample  ||| S:583 E:590 ||| NN
of  ||| S:590 E:593 ||| IN
the  ||| S:593 E:597 ||| DT
patient  ||| S:597 E:605 ||| NN
expressed  ||| S:605 E:615 ||| VBD
in  ||| S:615 E:618 ||| IN
percentage  ||| S:618 E:629 ||| NN
was  ||| S:629 E:633 ||| VBD
named  ||| S:633 E:639 ||| VBN
as  ||| S:639 E:642 ||| IN
platelet  ||| S:642 E:651 ||| JJ
collection  ||| S:651 E:662 ||| NN
efficiency  ||| S:662 E:673 ||| NN
and  ||| S:673 E:677 ||| CC
calculated  ||| S:677 E:688 ||| VBN
for  ||| S:688 E:692 ||| IN
each  ||| S:692 E:697 ||| DT
system ||| S:697 E:703 ||| NN
.  ||| S:703 E:705 ||| .
Mean  ||| S:705 E:710 ||| VB
platelet  ||| S:710 E:719 ||| JJ
collection  ||| S:719 E:730 ||| NN
efficiencies  ||| S:730 E:743 ||| NNS
were  ||| S:743 E:748 ||| VBD
66.6  ||| S:748 E:753 ||| CD
( ||| S:753 E:754 ||| -LRB-
min ||| S:754 E:757 ||| NN
:  ||| S:757 E:759 ||| :
56.9 ||| S:759 E:763 ||| CD
,  ||| S:763 E:765 ||| ,
max ||| S:765 E:768 ||| NNS
:  ||| S:768 E:770 ||| :
76.9 ||| S:770 E:774 ||| CD
) ||| S:774 E:775 ||| -RRB-
,  ||| S:775 E:777 ||| ,
58.3  ||| S:777 E:782 ||| CD
( ||| S:782 E:783 ||| -LRB-
min ||| S:783 E:786 ||| NN
:  ||| S:786 E:788 ||| :
27.3 ||| S:788 E:792 ||| CD
,  ||| S:792 E:794 ||| ,
max ||| S:794 E:797 ||| NNS
:  ||| S:797 E:799 ||| :
102.8 ||| S:799 E:804 ||| CD
) ||| S:804 E:805 ||| -RRB-
,  ||| S:805 E:807 ||| ,
50.8  ||| S:807 E:812 ||| CD
( ||| S:812 E:813 ||| -LRB-
min ||| S:813 E:816 ||| NN
:  ||| S:816 E:818 ||| :
27.2 ||| S:818 E:822 ||| CD
,  ||| S:822 E:824 ||| ,
max ||| S:824 E:827 ||| NNS
:  ||| S:827 E:829 ||| :
73 ||| S:829 E:831 ||| CD
)  ||| S:831 E:833 ||| -RRB-
for  ||| S:833 E:837 ||| IN
top  ||| S:837 E:841 ||| JJ
and  ||| S:841 E:845 ||| CC
bottom  ||| S:845 E:852 ||| JJ
bag  ||| S:852 E:856 ||| NN
system ||| S:856 E:862 ||| NN
,  ||| S:862 E:864 ||| ,
system  ||| S:864 E:871 ||| NN
using  ||| S:871 E:877 ||| VBG
citrated  ||| S:877 E:886 ||| JJ
tube ||| S:886 E:890 ||| NN
,  ||| S:890 E:892 ||| ,
and  ||| S:892 E:896 ||| CC
the  ||| S:896 E:900 ||| DT
system  ||| S:900 E:907 ||| NN
using  ||| S:907 E:913 ||| VBG
tube  ||| S:913 E:918 ||| NN
with  ||| S:918 E:923 ||| IN
Ficoll  ||| S:923 E:930 ||| NNP
and  ||| S:930 E:934 ||| CC
cell  ||| S:934 E:939 ||| NN
extraction  ||| S:939 E:950 ||| NN
kit ||| S:950 E:953 ||| NN
,  ||| S:953 E:955 ||| ,
respectively ||| S:955 E:967 ||| RB
.  ||| S:967 E:969 ||| .
Statistically  ||| S:969 E:983 ||| RB
significant  ||| S:983 E:995 ||| JJ
difference  ||| S:995 E:1006 ||| NN
was  ||| S:1006 E:1010 ||| VBD
found  ||| S:1010 E:1016 ||| VBN
only  ||| S:1016 E:1021 ||| RB
between  ||| S:1021 E:1029 ||| IN
the  ||| S:1029 E:1033 ||| DT
platelet  ||| S:1033 E:1042 ||| JJ
collection  ||| S:1042 E:1053 ||| NN
efficiencies  ||| S:1053 E:1066 ||| NNS
of  ||| S:1066 E:1069 ||| IN
systems  ||| S:1069 E:1077 ||| NNS
using  ||| S:1077 E:1083 ||| VBG
the  ||| S:1083 E:1087 ||| DT
tube  ||| S:1087 E:1092 ||| NN
with  ||| S:1092 E:1097 ||| IN
ficoll  ||| S:1097 E:1104 ||| NN
and  ||| S:1104 E:1108 ||| CC
cell  ||| S:1108 E:1113 ||| NN
extraction  ||| S:1113 E:1124 ||| NN
kit  ||| S:1124 E:1128 ||| NN
and  ||| S:1128 E:1132 ||| CC
the  ||| S:1132 E:1136 ||| DT
top  ||| S:1136 E:1140 ||| JJ
and  ||| S:1140 E:1144 ||| CC
bottom  ||| S:1144 E:1151 ||| JJ
bag  ||| S:1151 E:1155 ||| NN
system  ||| S:1155 E:1162 ||| NN
( ||| S:1162 E:1163 ||| -LRB-
p  ||| S:1163 E:1165 ||| CD
=  ||| S:1165 E:1167 ||| SYM
0.002 ||| S:1167 E:1172 ||| CD
) ||| S:1172 E:1173 ||| -RRB-
.  ||| S:1173 E:1175 ||| .
All  ||| S:1175 E:1179 ||| DT
three  ||| S:1179 E:1185 ||| CD
systems  ||| S:1185 E:1193 ||| NNS
could  ||| S:1193 E:1199 ||| MD
be  ||| S:1199 E:1202 ||| VB
used  ||| S:1202 E:1207 ||| VBN
for  ||| S:1207 E:1211 ||| IN
PRP  ||| S:1211 E:1215 ||| NNP
preparation ||| S:1215 E:1226 ||| NN
,  ||| S:1226 E:1228 ||| ,
but  ||| S:1228 E:1232 ||| CC
top  ||| S:1232 E:1236 ||| JJ
and  ||| S:1236 E:1240 ||| CC
bottom  ||| S:1240 E:1247 ||| JJ
bag  ||| S:1247 E:1251 ||| NN
system  ||| S:1251 E:1258 ||| NN
offers  ||| S:1258 E:1265 ||| VBZ
a  ||| S:1265 E:1267 ||| DT
slight  ||| S:1267 E:1274 ||| JJ
advantage  ||| S:1274 E:1284 ||| NN
over  ||| S:1284 E:1289 ||| IN
the  ||| S:1289 E:1293 ||| DT
system  ||| S:1293 E:1300 ||| NN
using  ||| S:1300 E:1306 ||| VBG
Ficoll  ||| S:1306 E:1313 ||| NNP
and  ||| S:1313 E:1317 ||| CC
cell  ||| S:1317 E:1322 ||| NN
extraction  ||| S:1322 E:1333 ||| NNS
kit  ||| S:1333 E:1337 ||| VBP
regarding  ||| S:1337 E:1347 ||| VBG
the  ||| S:1347 E:1351 ||| DT
platelet  ||| S:1351 E:1360 ||| JJ
collection  ||| S:1360 E:1371 ||| NN
efficiency ||| S:1371 E:1381 ||| NN
.  ||| S:1381 E:1383 ||| .
